18 December 2014
Manchester scientists have helped to improve our understanding of how leukaemia cells become resistant to multiple anti-cancer drugs.
16 December 2014
Manchester scientists now have access to new research equipment that lets them interrogate tumour tissue samples more thoroughly than ever before.
11 December 2014
A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports.
10 December 2014
Manchester scientists have explored the role of three molecules in controlling the process of cell division in a bid to gain new insight into the transmission of vital signals from a cell’s exterior to its interior.
09 December 2014
Doctors in Manchester have partnered with researchers in London to carry out a study of a potential new anti-cancer drug.
04 December 2014
An international study involving Manchester researchers has found that for previously untreated lung cancer patients with a particular genetic change, a new targeted therapy is better than standard chemotherapy.
03 December 2014
Manchester researchers have explored a risk stratification model based on lymph node characteristics and have shown a high level of confidence in confirming a true lack of lung cancer in the lymph nodes of patients with a negative lymph node sample.
02 December 2014
Doctors and scientists from The University of Manchester have identified changes in a gene, which can increase the risk of developing brain tumours in children with a rare inherited condition called Gorlin syndrome.
01 December 2014
Research led by a University of Manchester academic on the BRCA gene mutation in the Jewish population shows that the current process of identifying people which relies on assessing someone’s family history, misses half the people who have the mutation and are at risk of developing cancer.
26 November 2014
Scientists in Manchester are benefitting from a major makeover of tissue-based research facilities that they can use for ground-breaking research.
25 November 2014
Scientists in Manchester have discovered a potential weakness in cancer’s ability to return or become resistant to treatment, by targeting the ‘fuel’ part of stem cells which allows tumours to grow.
21 November 2014
The Cancer Research Technology Pioneer Fund (CPF) have announced a collaboration with the Cancer Research UK Manchester Institute Drug Discovery Unit to develop a promising class of drugs called RET inhibitors to treat cancer.
20 November 2014
Manchester researchers have identified a potential test to predict which patients with neck cancer may not benefit from conventional treatment and may require a different therapeutic approach.
19 November 2014
Scientists in Manchester have helped to identify a ‘signature’ of characteristic genetic changes in breast cells that could indicate the first steps towards cancer.
19 November 2014
A new insight into immune cells by scientists at The University of Manchester could lead to more effective drug treatments.
17 November 2014
Scientists in Manchester, working with colleagues in Sweden, have identified how a new anti-cancer drug targets tumour cells over healthy cells.
14 November 2014
Manchester scientists have found more than 400 ‘blind spots’ in DNA which could hide cancer-causing gene faults.
11 November 2014
Researchers in Manchester are leading the way in recruiting cancer patients to clinical trials in radiotherapy.
10 November 2014
Manchester scientists are investigating a method to better identify patients who may have Lynch syndrome – a condition that greatly increases the risk of developing bowel cancer.
07 November 2014
Scientists in Manchester have developed a new method to quickly and more accurately investigate vital cell communication – a process that often goes wrong in cancer.
06 November 2014
Manchester scientists have shown that a new drug inhibits the growth of tumours in the lab and that its effectiveness is improved by combining it with radiotherapy – suggesting a new approach that could be used in the clinic.
05 November 2014
Work by University of Manchester scientists has explored what allows some cases of Ductal Carcinoma in Situ (DCIS), a non-invasive form of breast cancer, to resist treatment and come back, as well as identifying a potential new target to improve the effectiveness of radiotherapy.
30 October 2014
Scientists in Manchester have further explored the properties of cells that could have an application in anti-cancer therapies.
27 October 2014
A study involving doctors from Manchester, working alongside researchers from UCL and other UK hospitals, has found no benefit for a combined treatment approach in lung cancer patients with secondary brain tumours.
27 October 2014
A Manchester-based scientist has teamed up with a Pennsylvanian fashion designer to create a dress showing how prostate cancer spreads in the body.
23 October 2014
The University of Manchester has been awarded £24 million for three large projects, two of which will drive forward the development of clinical sample testing and improve our understanding of basic cancer cell biology.
17 October 2014
A study in Manchester has explored a method to intensify the radiation dose for patients with head and neck cancer and shown that their new approach is safe and well-tolerated – offering the potential to better treat this disease.
16 October 2014
A Manchester-led study looking at controlling relapse in children with leukaemia has recently reported its findings – giving doctors more information on the best treatment approach for the disease.
09 October 2014
Researchers in Manchester have investigated which patients with lung cancer could most benefit from undergoing an alternative method for tissue biopsy – potentially reducing the risk of a collapsed lung for some patients.
06 October 2014
Research by scientists in Manchester has found that breast tissue cells can reawaken and continue to grow following treatment – findings that have implications for the design of breast cancer therapies.
01 October 2014
Treating cancers with immunotherapy and radiotherapy at the same time could stop them from becoming resistant to treatment.
30 September 2014
A study by Manchester researchers has shown that a boost dose of radiotherapy delivered to patients with higher risk prostate cancer is well tolerated.
29 September 2014
Referrals for genetic counselling and testing for breast cancer risk more than doubled across the UK, after actress Angelina Jolie announced in May 2013 that she tested positive for a BRCA1 gene mutation and underwent a double mastectomy.
26 September 2014
Manchester scientists have discovered more about the role of a particular gene in the formation of blood cells – work that could help improve understanding of cancer development.
25 September 2014
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.